p90(RSK) blocks bad-mediated cell death via a protein kinase C-dependent pathway

224Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Although activation of protein kinase C (PKC) is known to promote cell survival and protect against cell death, the PKC targets and pathways that serve this function have remained elusive. Here we demonstrate that two potent activators of PKC, 12-O-tetradecanoyl-phorbol-13-acetate and bryostatin, both stimulate phosphorylation of Bad at Ser112, a site known to regulate apoptotic cell death by interleukin-3. PKC inhibitors but not PI 3-kinase/Akt inhibitors block 12-O-tetradecanoyl-phorbol-13-acetate- stimulated Bad phosphorylation. PKC isoforms tested in vitro were unable to phosphorylate Bad at Ser112, suggesting that PKC acts indirectly to activate a downstream Bad kinase, p90(RSK) and family members RSK-2 and RSK-3 are activated by phorbol ester and phosphorylate Bad at Ser112 both in vitro and in vivo. p90(RSK) stimulates binding of Bad to 14-3-3 and blocks Bad-mediated cell death in a Ser112-dependent manner. These findings suggest that p90(RSK) can function in a PKC-dependent pathway to promote cell survival via phosphorylation and inactivation of Bad-mediated cell death.

Cite

CITATION STYLE

APA

Tan, Y., Ruan, H., Demeter, M. R., & Comb, M. J. (1999). p90(RSK) blocks bad-mediated cell death via a protein kinase C-dependent pathway. Journal of Biological Chemistry, 274(49), 34859–34867. https://doi.org/10.1074/jbc.274.49.34859

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free